Top four aesthetics business news of the week

Last week we reported many business developments shaping the aesthetics market.

The trend continues this week as Allergan sold its generics business, among other top business items.

GC Aesthetics launches IPO

GC Aesthetics plc commenced an initial public offering of 5,350,000 of its ordinary shares. Read more

Dynatronics receives CE Mark for Solaris products

Dynatronics Corporation announced it has received CE Mark approval for its Solaris therapeutic modality products, allowing the company to sell the products in Europe and other countries worldwide. Read more

Suneva closes $15M investment by Almirall , expands business development

Suneva Medical Inc. announced the closing of a $15 million equity investment by Almirall Inc. Read more

Allergan divests global generics business to Teva Pharma

Allergan announced that Teva Pharmaceuticals Industries Ltd. will acquire Allergan’s global generic pharmaceutical business for $40.5 billion. Read more